Methotrexate decreases tenofovir exposure in antiretroviral-suppressed individuals living with HIV

BACKGROUND: To mitigate increased risk of premature cardiovascular disease in antiretroviral therapy (ART) suppressed adults living with HIV (PWH), low dose methotrexate (LDMTX) was evaluated in a multicenter randomized placebo controlled clinical trial of 176 PWH taking various ART regimens (ACTG A...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Acquir Immune Defic Syndr
Asıl Yazarlar: Gingrich, David, Deitchman, Amelia N, Kantor, Amy, Huang, Liusheng, Stein, James H, Currier, Judith S, Hsue, Priscilla Y, Ribaudo, Heather J, Aweeka, Francesca T
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8132144/
https://ncbi.nlm.nih.gov/pubmed/33177476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002502
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller